email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
721 - 735
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Genuine Biotech Files for Hong Kong IPO to Support Novel Drugs Portfolio
$5.00
Available
Radiopharm Forms Collaboration to Develop PD-L1 Diagnostic/Therapeutic Antibody
$5.00
Available
ProfoundBio Cleared to Start US Trials of ADC for Solid Tumor Cancers
$5.00
Available
Ablaze Plans $100 Million Facility in Chengdu Medical City for Targeted Radiation Therapies
$5.00
Available
Zenas to Start China Trials of Thyroid Eye Disease Therapy
$5.00
Available
Sironax Closes $200 Million Round for Novel Degenerative Disease Therapies
$5.00
Available
Structure Therapeutics Closes $33 Million for Novel Small Molecule Drugs
$5.00
Available
OriCell Closes $120 Million Round for Cell Therapies and Bispecific Candidates
$5.00
Available
GluBio Completes $22 Million Funding for Protein Degradation Candidates
$5.00
Available
CSPC Pharma Out-Licenses Claudin18.2 ADC in Deal with $1 Billion in Commercial Milestones
$5.00
Available
Maxvax Completes $74 Million Series B for China Vaccine Development
$5.00
Available
BridGene Closes $38.5 Million Funding from China Investors for Novel Small Molecule Targets
$5.00
Available
Legend Bio Plans to Raise $250 Million in Public Offering of Shares
$5.00
Available
HanX and Lepu Approved to Launch PD-1 mAb for Colorectal Cancer
$5.00
Available
InvestisBio Completes $296 Million IPO on the Shanghai STAR Board
$5.00
Available